A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

NCT04252846 · clinicaltrials.gov ↗

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Generalized Epilepsy
Partial Onset Seizures
Generalised Tonic-Clonic Seizures

Interventions

DRUG: Perampanel

Sponsor

Eisai Limited